School of Engineering

Prof. Laura Lewis discusses her research exploring how the flow of cerebrospinal fluid (CSF) in your brain while you sleep can help eliminate “waste," like “excess proteins and other molecules that can be toxic, if not removed,” reports Lydia Denworth for Scientific American. “Lewis found that CSF also flows when people are awake but less effectively,” explains Denworth. “Lewis’s conclusion: sleep, a state that is essential for human health, has a distinct pattern of CSF flow—and that pattern changes as the stages of sleep shift.” 

WBUR reporter Rachell Sanchez-Smith spotlights two health tech devices being developed by Prof. Yoel Fink and Prof. Canan Dağdeviren, respectively, that aim to “give the wearers — and their doctors — a clearer picture of their overall health.” Fink has created “a thread capable of storing data, running artificial intelligence algorithms, sensing motion and sound, and communication through Bluetooth,” while Dağdeviren’s wearable ultrasound scanner can be used to make breast cancer screening “more comfortable and more accurate,” explains Sanchez-Smith.  

Researchers at MIT have “developed an antenna that can adjust its frequency range by physically changing in its shape” reports Mrigakshi Dixit for Interesting Engineering. “Instead of standard, rigid metal, this antenna is made from metamaterials — special engineered materials whose properties are based on their geometric structure,” explains Dixit. “It could be suitable for applications like transferring energy to wearable devices, tracking motion for augmented reality, and enabling wireless communication.”

In a new LinkedIn ranking, MIT has been named one of the best colleges for long-term career success “because of its place in the top 5 for entrepreneurship, C-suite experience (CEO, CFO, etc.), internships, and recruiter demand,” reports Madison Lucchesi for Boston.com. 

With a time of 1 hour, 52 minutes, and 20 seconds, Milo Knowles '19, SM '20 was awarded first place in the Olympic distance elite division at the 2025 Boston Triathlon, reports Emma Healy for The Boston Globe. 

MIT has been named among the top US schools for long-term career success in a new LinkedIn ranking, reports Ava Berger for The Boston Globe. “The list compiles public member data from the networking platform based on five factors: job placement, internships and recruiter demand, career success, network strength, and 'the unique skills' gained by graduates,” writes Berger. 

MIT researchers have developed a new method to fortify foods and beverages as part of an effort to combat global malnutrition, reports Insha Naureen for Food Ingredients First. “The innovation offers a potential solution to the global malnutrition crisis due to iron deficiency, which can lead to anemia, impaired brain development in children, and increased infant mortality,” Naureen explains. “Beyond iron and iodine, this platform can also deliver multiple micronutrients or bioactive compounds in a single formulation, enabling targeted nutritional strategies,” explains Ana Jaklenec, a principal investigator at the Koch Institute. 

Using AI, researchers at MIT have developed new antibiotics for gonorrhoea and MRSA, two infections that are typically hard to treat. The team “trained the AI to help it learn how bacteria was affected by different molecular structures built of atoms in order to design new antibiotics,” writes Ruth Stainer for the Daily Mail. “[A]nything too similar to the current antibiotics available, or with the potential to be toxic to human beings, was eradicated.” 

Researchers at MIT used AI to “design antibiotics that can tackle hard-to-treat infections gonorrhoea and MRSA,” reports ITV News. "Our work shows the power of AI from a drug design standpoint, and enables us to exploit much larger chemical spaces that were previously inaccessible,” says Prof. James Collins. 

Researchers at MIT have developed a new nutrient fortification process “to deliver essential nutrients such as iron and iodine in foods and drinks,” reports Ben Cornwell for New Food Magazine. “With around two billion people worldwide suffering from iron deficiency, which can lead to anemia, impaired brain development in children and higher infant mortality, this solution from MIT could address a major global issue,” writes Cornwell. 

Using generative AI, researchers at MT have designed new antibiotics to combat MRSA and gonorrhea, reports James Gallagher for the BBC. "We're excited because we show that generative AI can be used to design completely new antibiotics," says Prof. James Collins. "AI can enable us to come up with molecules, cheaply and quickly and in this way, expand our arsenal, and really give us a leg up in the battle of our wits against the genes of superbugs."

Prof. Daniela Rus, director of CSAIL, speaks with CBS News reporter Tony Dokoupil about her work developing AI-powered robots. “AI and robots are tools,” says Rus. “They are tools created by the people, for the people. And like any other tools they’re not inherently good or bad; they are what we choose to do with them. And I believe we can choose to do extraordinary things.” 

Prof. Philip Isola speaks with Fast Company reporter Victor Dey about the impact and use of agentic AI. “In some domains we truly have automatic verification that we can trust, like theorem proving in formal systems. In other domains, human judgment is still crucial,” says Isola. “If we use an AI as the critic for self-improvement, and if the AI is wrong, the system could go off the rails.”

Writing for Fast Company, Rizwan Virk '92 explains the findings of his new book, “The Simulation Hypothesis.” The book explores the mysteries of quantum weirdness, “the strange nature of time and space, information theory & digital physics, spiritual/religious arguments, and even an information-based way to explain glitches in the matrix,” writes Virk.  

Prof. Giovanni Traverso and his lab are developing “a transdermal patch that could provide women with long-term contraception,” reports The Boston Globe Editorial Board. “The lab is also developing probiotic medications to treat abnormalities in the vaginal microbiome, a condition associated with risks including painful infection and premature birth.”